期刊文献+

考夫克和卡贝治疗分泌性中耳炎的机制研究 被引量:3

Study on the Mechanisms of Treating OME with Ambroxol Hydrochloride Tablets and Bromhexine Hydrochloride Injection
暂未订购
导出
摘要 目的研究抗过敏药物考夫克和卡贝治疗分泌性中耳炎的机制。方法采用卵蛋白致敏大鼠变态反应分泌性中耳炎动物模型,使用考夫克和卡贝分别予以治疗,在用药第7天和第14天采血及取PBS中耳冲洗液,检测两者中干扰素γ(IFN-γ)、白细胞介素4(IL-4)、白三烯C-4(LTC-4)、前列腺素D2(PGD2)和血小板活化因子(PAF)含量。结果用药第7天,血清中及中耳冲洗液中上述细胞因子均较生理盐水治疗组偏低(P<0.05);与对照组比较,部分项目差异不显著(P>0.05),但仍有个别项目有显著性差异(P<0.05)。用药第14天,血清中及中耳冲洗液中上述细胞因子含量均恢复到正常水平,与对照组比较差异不显著(P>0.05)。结论考夫克或者卡贝的作用机制是通过抑制I型变态反应,达到有效治疗分泌性中耳炎(OME)的作用。 Objective To investigate the mechanisms of treating OME with Ambroxol Hydrochloride tablets and Bromhexine Hydrochloride injection. Method The animal model of OME was made and was treated with Ambroxol Hydrochloride tablets( AH) and Bromhexine Hydrochloride injection( BH). At the date of 7 and 14,the middle ear rinses and serum were collected. The levels of IFN-γ,IL-4,LTC-4,PGD2 and PAF were detected.Result Compared with normal saline group, the levels of IFN-γ, IL-4, LTC-4, PGD2 and PAF of the experimental group that treated with AH and BH were significantly decreased( P〈0. 05) at the date of 7,but the differences of other parameters between the control group and the experimental group that treated with AH and BH were not significant. At the date of 14,compared with the control group,the differences of the levels of IFN-γ,IL-4,LTC-4,PGD2 and PAF of the experimental group that treated with AH and BH were not significant( P〉0. 05). Conclusion The mechanism of action of Ambroxol Hydrochloride tablets and Bromhexine Hydrochloride injection is related to inhibiting type I allergy.
出处 《实验动物科学》 2015年第4期6-9,共4页 Laboratory Animal Science
关键词 分泌性中耳炎 变态反应 细胞因子 OME allergic reaction cytokine
  • 相关文献

参考文献4

二级参考文献29

  • 1孙荣,洪苏玲,唐新业.变态反应性中耳炎动物模型的建立及Ⅰ型变态反应与分泌性中耳炎关系的探讨[J].临床耳鼻咽喉科杂志,2005,19(4):170-172. 被引量:17
  • 2Hurst D S. Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein leves in both middle ear effusion and mucosal biopsies.Laryngoscope,1996,106:1128-1137.
  • 3Hardy S M, Heavner S B, White D R, et al. Late-phase allergy and eustachian tube dysfunction. Otolaryngol Head Neck Surg,2001, 125:339-345.
  • 4Pollock H W, Ebert C S, Dubin M G, et al. The role of soluble interleukin -4 receptor and interleukin-5 antibody in preventing late-phase allergy -induced eustachian tube dysfunction.Otolaryngol Head Neck Surg,2002,127:169-176.
  • 5Doyle W J. The link between allergic rhinitis and otitis media. Curr Opin Allergy Clin Immunol,2002,2:21-25.
  • 6Hardy SM, Heavner SB, White DR, et al. Late-phase allergy and eustachian tube dysfunction[J]. Otolaryn- gol Head Neck Surg, 2001,125(4) :339-345.
  • 7Labadie RF, Jewett BS, Hart CF, et al. Allergy increases susceptibility to otitis media with effusion in a rat model[J]. Otolaryngol Head Neck Surg, 1999,121 (6) :687-692.
  • 8Williver R, Kaul T, Orga P. The appearance of cell- bound IgE in respiratory tract epithelium after respiratory tract viral infection[J]. N Engl J Med, 1980,303 (21):1198-1202.
  • 9Sobol SE, Taha R, Schloss MD, et al. Th2 cytokine expression in atopic children with otitis media with ef- fusion[J]. J Allergy Clin Immunol, 2002,110(1) : 125- 130.
  • 10Nguyen LH, Manoukian JJ, Sobol SE, et al. Similar allergic inflammation in the middle ear and the upper airway. evidence linking otitis media with effusion to the united airways concept[J]. J Allergy Clin Immunol,2004,114(5):1110-1115.

共引文献25

同被引文献33

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部